Glioblastoma. Past, present and future
<p>Glioblastoma is the most advanced, common and malignant stage of primary brain tumors in adults. It represents about 57% of all glial tumors. In adults it is more common in the cerebral hemispheres, while in children it is more common in the posterior fossa. Its infiltrative growth is extre...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Spanish |
Published: |
Centro Provincial de Información de Ciencias Médicas. Cienfuegos
2024-07-01
|
Series: | Medisur |
Subjects: | |
Online Access: | http://medisur.sld.cu/index.php/medisur/article/view/45195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832576843700502528 |
---|---|
author | Adriel Herrero Díaz Luis Manuel Abreu Pereira Ilian Esteban Tarife Romero Diana Rosa González Tamayo |
author_facet | Adriel Herrero Díaz Luis Manuel Abreu Pereira Ilian Esteban Tarife Romero Diana Rosa González Tamayo |
author_sort | Adriel Herrero Díaz |
collection | DOAJ |
description | <p>Glioblastoma is the most advanced, common and malignant stage of primary brain tumors in adults. It represents about 57% of all glial tumors. In adults it is more common in the cerebral hemispheres, while in children it is more common in the posterior fossa. Its infiltrative growth is extremely rapid. The present literature review aims to describe the clinical characteristics and treatment of glioblastoma as an aggressive brain tumor. A bibliographic search was carried out, resulting in 29 bibliographic sources, available in Scielo, PubMed, Dialnet and Elsevier, in which the information reviewed, was supported. Grade IV glioblastoma or astrocytoma is an aggressive, poorly differentiated tumor with a high degree of malignancy, invariably associated with a poor prognosis. Glioblastoma is positioned as the most aggressive form of brain cancer. Its treatment is based on tumor cytoreduction, combined with chemo and radiotherapy. The current numbers show unfavorable prognoses associated with this neoplasia. The improvement and creation of new anticancer therapies are the future hopes in the fight against this pathology.</p> |
format | Article |
id | doaj-art-a1d5418860f640728ec343e80d7cc3fb |
institution | Kabale University |
issn | 1727-897X |
language | Spanish |
publishDate | 2024-07-01 |
publisher | Centro Provincial de Información de Ciencias Médicas. Cienfuegos |
record_format | Article |
series | Medisur |
spelling | doaj-art-a1d5418860f640728ec343e80d7cc3fb2025-01-30T21:29:03ZspaCentro Provincial de Información de Ciencias Médicas. CienfuegosMedisur1727-897X2024-07-012248218272540Glioblastoma. Past, present and futureAdriel Herrero Díaz0Luis Manuel Abreu Pereira1Ilian Esteban Tarife Romero2Diana Rosa González Tamayo3Universidad de Ciencias Médicas de Villa Clara. Villa ClaraFacultad de Ciencias Médicas de Mayabeque. MayabequeFacultad de Ciencias Médicas de Mayabeque. MayabequeHospital Provincial Universitario Arnaldo Milián Castro. Villa Clara<p>Glioblastoma is the most advanced, common and malignant stage of primary brain tumors in adults. It represents about 57% of all glial tumors. In adults it is more common in the cerebral hemispheres, while in children it is more common in the posterior fossa. Its infiltrative growth is extremely rapid. The present literature review aims to describe the clinical characteristics and treatment of glioblastoma as an aggressive brain tumor. A bibliographic search was carried out, resulting in 29 bibliographic sources, available in Scielo, PubMed, Dialnet and Elsevier, in which the information reviewed, was supported. Grade IV glioblastoma or astrocytoma is an aggressive, poorly differentiated tumor with a high degree of malignancy, invariably associated with a poor prognosis. Glioblastoma is positioned as the most aggressive form of brain cancer. Its treatment is based on tumor cytoreduction, combined with chemo and radiotherapy. The current numbers show unfavorable prognoses associated with this neoplasia. The improvement and creation of new anticancer therapies are the future hopes in the fight against this pathology.</p>http://medisur.sld.cu/index.php/medisur/article/view/45195glioblastomanecrosisneoplasiasdiagnóstico |
spellingShingle | Adriel Herrero Díaz Luis Manuel Abreu Pereira Ilian Esteban Tarife Romero Diana Rosa González Tamayo Glioblastoma. Past, present and future Medisur glioblastoma necrosis neoplasias diagnóstico |
title | Glioblastoma. Past, present and future |
title_full | Glioblastoma. Past, present and future |
title_fullStr | Glioblastoma. Past, present and future |
title_full_unstemmed | Glioblastoma. Past, present and future |
title_short | Glioblastoma. Past, present and future |
title_sort | glioblastoma past present and future |
topic | glioblastoma necrosis neoplasias diagnóstico |
url | http://medisur.sld.cu/index.php/medisur/article/view/45195 |
work_keys_str_mv | AT adrielherrerodiaz glioblastomapastpresentandfuture AT luismanuelabreupereira glioblastomapastpresentandfuture AT ilianestebantariferomero glioblastomapastpresentandfuture AT dianarosagonzaleztamayo glioblastomapastpresentandfuture |